[go: up one dir, main page]

WO2012016147A3 - Ligands for selective asymmetric hydroformylation - Google Patents

Ligands for selective asymmetric hydroformylation Download PDF

Info

Publication number
WO2012016147A3
WO2012016147A3 PCT/US2011/045897 US2011045897W WO2012016147A3 WO 2012016147 A3 WO2012016147 A3 WO 2012016147A3 US 2011045897 W US2011045897 W US 2011045897W WO 2012016147 A3 WO2012016147 A3 WO 2012016147A3
Authority
WO
WIPO (PCT)
Prior art keywords
ligands
asymmetric hydroformylation
selective asymmetric
selective
hydroformylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/045897
Other languages
French (fr)
Other versions
WO2012016147A2 (en
Inventor
Christopher James Cobley
Gary Noonan
Matthew Clarke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Priority to EP11813250.5A priority Critical patent/EP2598510A4/en
Priority to JP2013522001A priority patent/JP2013532691A/en
Publication of WO2012016147A2 publication Critical patent/WO2012016147A2/en
Publication of WO2012016147A3 publication Critical patent/WO2012016147A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505—Asymmetric hydroformylation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/185—Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2495—Ligands comprising a phosphine-P atom and one or more further complexing phosphorus atoms covered by groups B01J31/1845 - B01J31/1885, e.g. phosphine/phosphinate or phospholyl/phosphonate ligands
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • C07F9/65683—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32—Addition reactions to C=C or C-C triple bonds
    • B01J2231/321—Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0261—Complexes comprising ligands with non-tetrahedral chirality
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/822—Rhodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

In an aspect, the invention provides compounds of the formula 4: wherein the constituent variables are defined herein.
PCT/US2011/045897 2010-07-30 2011-07-29 Ligands for selective asymmetric hydroformylation Ceased WO2012016147A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP11813250.5A EP2598510A4 (en) 2010-07-30 2011-07-29 Ligands for selective asymmetric hydroformylation
JP2013522001A JP2013532691A (en) 2010-07-30 2011-07-29 Ligands for selective asymmetric hydroformylation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36923810P 2010-07-30 2010-07-30
US61/369,238 2010-07-30

Publications (2)

Publication Number Publication Date
WO2012016147A2 WO2012016147A2 (en) 2012-02-02
WO2012016147A3 true WO2012016147A3 (en) 2012-04-19

Family

ID=45530741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/045897 Ceased WO2012016147A2 (en) 2010-07-30 2011-07-29 Ligands for selective asymmetric hydroformylation

Country Status (3)

Country Link
EP (1) EP2598510A4 (en)
JP (1) JP2013532691A (en)
WO (1) WO2012016147A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104744514B (en) * 2013-12-27 2018-03-23 中国科学院上海药物研究所 A kind of chiral phosphorus alkene part, synthetic method and its application in asymmetric reaction
US9308527B2 (en) 2014-03-17 2016-04-12 Eastman Chemical Company Phosphorous compounds useful as ligands and compositions and methods regarding them
US10183961B1 (en) * 2017-11-28 2019-01-22 Eastman Chemical Company Highly isoselective catalyst for alkene hydroformylation
US10144751B1 (en) 2017-11-28 2018-12-04 Eastman Chemical Company Highly isoselective catalyst for alkene hydroformylation
AU2021268345A1 (en) 2020-05-05 2022-11-10 Nuvalent, Inc. Heteroaromatic macrocyclic ether chemotherapeutic agents
WO2021226208A2 (en) 2020-05-05 2021-11-11 Nuvalent, Inc. Heteroaromatic macrocyclic ether chemotherapeutic agents
EP4204429A1 (en) * 2020-08-25 2023-07-05 Eastman Chemical Company Phospholane-phosphite ligands for alkene hydroformylation catalysts
EP4204388A1 (en) * 2020-08-25 2023-07-05 Eastman Chemical Company Olefin hydroformylation processes using hydrocarbon solvents and fluorinated solvents in the presence of phospholane-phosphite ligands
KR20240087788A (en) 2021-10-01 2024-06-19 뉴베일런트, 아이엔씨. Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3846020B2 (en) * 1998-04-07 2006-11-15 三菱化学株式会社 Bisphosphite compound and method for producing aldehydes using the compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ARENA, C. G. ET AL.: "Structural Control in Palladium(II)-Catalyzed Enantiose lective Allylic Alkylation by New Chiral Phosphine-Phosphite and Pyridine-Phosphite Ligands.", TETRAHEDRON ASYMMETRY, vol. 11, 2000, pages 2765 - 2779, XP004228727 *
FERNANDEZ-PEREZ, H. ET AL.: "Highly Modular P-OP Ligands for Asymmetric Hydrogenation: Synthesis, Catalytic Activity, and Mechanism.", CHEM. EUR. J., vol. 16, 23 April 2010 (2010-04-23), pages 6495 - 6508, XP055083468 *
ROBERT, T. ET AL.: "Asymmetric Hydroformylation Using Taddol-Based Chiral Phosphine-Phosphite Ligands.", ORGANOMETALLICS, vol. 29, 18 December 2009 (2009-12-18), pages 478 - 483, XP055083473 *
See also references of EP2598510A4 *

Also Published As

Publication number Publication date
WO2012016147A2 (en) 2012-02-02
EP2598510A4 (en) 2014-02-26
JP2013532691A (en) 2013-08-19
EP2598510A2 (en) 2013-06-05

Similar Documents

Publication Publication Date Title
WO2012016147A3 (en) Ligands for selective asymmetric hydroformylation
HUS2000040I1 (en) Fungicide-substituted 2- [2-haloalkyl-4- (phenoxyphenyl] -1- [1,2,4] triazol-1-yl-ethanol compounds
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
EP2875029B8 (en) 5,5-heteroaromatic anti-infective compounds
HK1197066A1 (en) Z-selective ring-closing metathesis reactions
PT2649242E (en) Method for building structures, particularly passages under operating railways or the like.
WO2013003652A8 (en) Multispecific stacked variable domain binding proteins
AP2011005706A0 (en) New compounds.
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
EP2282735A4 (en) Compounds, compositions and methods for making the same
ZA201204939B (en) Process for the carbonylation of ehtylenically unisaturated compounds, novel carbonylation ligands and catalyst systsems incorporating such ligands
IL245849A0 (en) Process for the preparation of complexes of 68ga.
WO2013016229A3 (en) Heteroleptic pyrrolecarbaldimine precursors
WO2012064743A3 (en) Methods for improving heart function
WO2015012916A3 (en) Metal-ligand coordination polymer nanoparticles and methods for making
WO2012106680A3 (en) Methods and compositions for chemical drying producing struvite
EP2687520A4 (en) Method for producing 1,2-benzisothiazol-3-one compound
EP2687519A4 (en) 1,2-benzisothiazol-3-one compound production method
WO2011117271A3 (en) Fungicidal mixtures based on azolopyrimidinylamines
EP2883870B8 (en) Method for producing 1,4-benzoxazine compound
WO2012170720A3 (en) Methods and compositions for treating brain cancer
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2012106702A3 (en) Treatment of leukemia
SI2640697T1 (en) 4-substituted-3-phenylsulfanylmethyl-bicyclo(3.1.0)hexane compounds as mglur 2/3 antagonists

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11813250

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2013522001

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2011813250

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011813250

Country of ref document: EP